Tested Applications
| Positive FC detected in | rat splenocytes cells |
Recommended dilution
| Application | Dilution |
|---|---|
| Flow Cytometry (FC) | FC : 0.5 ug per 10^6 cells in 100 μl suspension |
| This reagent has been tested for flow cytometric analysis. It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
CL594-65237 targets CD43 in FC applications and shows reactivity with Rat samples.
| Tested Reactivity | Rat |
| Cited Reactivity | rat |
| Host / Isotype | Mouse / IgG1, kappa |
| Class | Monoclonal |
| Type | Antibody |
| Immunogen |
Rat thymocyte membrane glycoproteins Predict reactive species |
| Full Name | sialophorin |
| Calculated Molecular Weight | 38 kDa |
| Gene Symbol | CD43 |
| Gene ID (NCBI) | 24796 |
| RRID | AB_3084692 |
| Conjugate | CoraLite®594 Fluorescent Dye |
| Excitation/Emission Maxima Wavelengths | 588 nm / 604 nm |
| Excitation Laser | Yellow-Green Laser (561 nm) |
| Form | Liquid |
| Purification Method | N/A |
| UNIPROT ID | P13838 |
| Storage Buffer | PBS with 0.09% sodium azide, pH 7.3. |
| Storage Conditions | Store at 2-8°C. Avoid exposure to light. Stable for one year after shipment. |
Protocols
| Product Specific Protocols | |
|---|---|
| FC protocol for CL594 CD43 antibody CL594-65237 | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
What published studies show
The Anti-Rat CD43 (W3/13) antibody (Cat# CL594-65237) has 1 citation to date. It appears in J Nanobiotechnology (Impact Factor 15), published in 2026. The cited study investigated microneedle patches delivering GLP-1 receptor agonist-loaded nanoparticles for rheumatoid arthritis treatment, placing this antibody in the research fields of nanomedicine, drug delivery systems, and inflammatory disease therapy. Flow cytometry was the application used in the study.
| Species | Application | Title |
|---|---|---|
J Nanobiotechnology Microneedle patches deliver targeted GLP-1RAs-loaded nanoparticles for the treatment of rheumatoid arthritis. |

